A new study led by the Centenary Institute in Australia has demonstrated the use of cancer drug Ponatinib as a potential treatment for cerebral cavernous malformations (CCM) in young individuals.
8 November 2018 News
20 September 2018 projects
Germany-based pharmaceutical company, Boehringer Ingelheim, is constructing a new tablet production facility in Ingelheim, Germany, with an estimated investment of more than €85m ($97.2m).
29 July 2013 projects
Dainippon Sumitomo Pharma (DSP) opened a new chemistry research building in Osaka, Japan, in June 2013.
17 April 2008 projects
Boehringer Ingelheim is a Germany-based company with interests in pharmaceuticals, biopharmaceuticals, chemicals and ani
13 May 2001 projects
In 2000, Sumitomo Pharmaceutical Company completed the construction of a manufacturing plant in 2000 in Ibaraki city, near Osaka, Japan.
12 February 2001 projects
In 2000, biotechnology company Boehringer Ingelheim awarded Stuttgart company Life Science Meissner & Wurst an engineering contract for the expansion of its Biberach plant.